. Determination of ibuprofen, ketoprofen, diclofenac and phenylbutazone in bovine milk by gas chromatography tandem mass spectrometry. Food Additives and Contaminants, 2008, 25 (12) the within-lab reproducibility at the three levels of fortification (5, 7.5 and 10 ng ml -1 ) was less than 8 % for IBP, DCF and PBZ respectively. Poor precision was obtained for KPF with an RSD value of 28 %.
PBZ is a pyrazole derivative, IBP and KPF are propionic acid derivatives and DCF is an aniline derivative.
In the USA a survey was carried out involving 2000 veterinarians whose practices dealt 50% of the time with food producing animals [U.S Code of Federal Regulations, 1988] . The survey showed that 93 % of veterinarians use NSAIDs on a regular basis.
Dairy practitioners reported more frequent use of NSAIDs than did beef practitioners.
Overall, veterinarians indicated that NSAIDs were an important group of compounds which were routinely used for the treatment of food producing animals [Kopcha, et al., 1992] . According to EU law, all substances for veterinary use need to be included in Annexes 1-3 of Regulation 2377/90 [European Commission, 1990] . This regulation establishes lists of compounds that have a fixed MRL (Annex I), that need no MRL (Annex II) or that have a provisional MRL (Annex III). PBZ and IBP are compounds that have not been included in Annexes 1-3 and have no maximum residue limit (MRL) established. Substances that have no MRL established are prohibited for use in food producing animals. DCF is listed in Annex I and a provisional MRL has been set for different animal species and target matrices. DCF is however prohibited for use in milk producing animals. KPF is listed in Annex II and is allowed for the application to species that produce milk but are not intended for human consumption. NSAIDs can cause adverse health effects in humans such as aplastic anaemia, gastrointestinal disorders and agranulocytosis [Insel, et al., 1990] and changes in renal function [Goodman , et al., 1992] . Longterm exposure to PBZ has caused kidney tumors in mice and liver tumors in rats [Kari, et al., 1995] . The widespread use of NSAIDs presents a potential risk to the consumer if food containing residues enter the food chain so there is a need for the development of methods to monitor compliance with legislation in the EU in a variety of animal tissues and products.
In the determination of NSAIDs in animal tissues PBZ has been shown to be extracted from equine plasma using acetonitrile [Hardee, et al., 1982; Neto, et al., 1996] or ethyl acetate [Grippa, et al., 2000] , from equine urine with methanol [Stanley, et al., 2007] or a mixture of dichloromethane:ethanol solution [Neto, et al., 1996] . PBZ has been shown to be extracted from bovine plasma using acetonitrile [Miksa, et al., 2005; Fiori, et al., 2004] or a straight forward ultra-centrifugation procedure [De Veau, et al., 1999] . IBP, KPF and DCF has been shown to be extracted from bovine plasma using acetontrile [Miksa, et al., 2005] . PBZ has been shown to be extracted from ovine, equine, and porcine muscle using a mixture of ethyl acetate: methanol and DL-dithio-threitol [Clarke, et al., 2002] . PBZ has been shown to be extracted from bovine kidney using a mixture of water: ammonium hydroxide [Clarke, et al., 2002] . PBZ has been shown to be extracted from bovine milk with a mixture of ethanol: ammonia [Martin, et al., 1983] . KPF has been shown to be extracted from bovine milk using acetonitrile [Daeseleire, et al., 2003] . The incorporation of a hydrolysis step at the beginning of the extraction procedure for the determination of NSAIDs is also reported in the literature. This hydrolysis step allows the deactivation of plasma bound proteins and the release of the protein bound NSAID residues. After hydrolysis PBZ has been shown to be extracted from bovine plasma using dichloromethane [Singh, et al., 1991] , from equine plasma with a mixture of dichloromethane:n-hexane:diethyl ether solution [Hines, et al., 2004] , porcine, ovine, bovine and caprine urine were extracted with chloroform [Igualada and Moragues, 2005] and equine urine was extracted with dichloromethane [Singh, et al., 1991] or diethyl ether [Gonzalez, et al., 1996] for the determination of PBZ. After hydrolysis or solvent extraction, solid phase extraction [SPE] is often used in the purification of extracts containing NSAIDs. Bovine plasma has been shown to be purified using C 18 SPE for the determination of PBZ and DCF [Gowik, et al., 1998 ], IBP, KPF, DCF and PBZ [Vinci, et al., 2006] and IBP, KPF and DCF [De Jong, et al., 1989] . Plasma from pigs and rabbits was purified using this approach to determine IBP, KPF, DCF and PBZ [Vinci, et al., 2006] . Equine plasma was purified using C 18 for the determination of IBP, KPF, DCF and PBZ simultaneously [Vinci, et al., 2006] or PBZ alone [Taylor and Westwood, 1995] or the C 18 was substituted for an Oasis HLB 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 [Quintana, et al., 2004] for the determination of PBZ. Bovine, equine and porcine muscle was purified using a Florisil SPE cartridge. Bovine muscle extracts were applied to an Oasis HLB TM cartridge for the removal of interferences in the determination of PBZ and KPF [Van Hoof, et al., 2004] . Bovine kidney extracts were applied to silica cartridges [Clarke, et al., 2002] and bovine plasma extracts were purified using affinity columns [Fiori, et al., 2004] for the determination of PBZ.
A few methods have been reported for the analysis of NSAIDs in animal tissues using LC-UV [Hardee et al., 1982; Grippa et al., 2000; De Veau, 1999; Martin, et al., 1983; Singh, et al., 1991; Gowik, et al., 1998; Taylor and Westwood, 1995; Quintana et al., 2004; Moragues, 2005; Vinci, et al., 2006; Van Hoof, et al., 2004] and GC-MS [Neto et al., 1996; Singh, et al., 1991; Hines et al., 2004; Gonzalez, et al., 1996; Taylor and Westwood, 1995] . There are few methods that analyse for IBP, KPF DCF and PBZ in animal products such as milk and those available are based on LC-UV [Martin, et al., 1983] for the determination of PBZ or LC-MS detection [Daeseleire, et al., 2003] for the determination of KPF and FLU. NSAIDs have been derivatised for GC-MS using the following derivatisation reagents; Methelut [Neto et al., 1996] , Bis(trimethylsilyl)
trifluoroacetamide [Singh, et al., 1991] , n-trimethylsulfonium hydroxide [Hines, et al., 2004] and N-methyl-N-(trimethylsilyl) fluoroacetaminde and Trimethylanilium hydroxide [Taylor and Westwood, 1995] . Gonzalez et al. monitors for IBP, KPF, DCF and PBZ simultaneously in equine plasma and urine by GC-MS in SIM mode used Methyl iodide/anhydrous potassium carbonate [Gonzalez, et al., 1996] as derivatisation agents.
The method developed in this study was based on a method developed by Vinci, et al., (2006) but adapted to include deuterated analogues of IBP, DCF and PBZ. LC-MS detection was replaced by GC-MS/MS coupled with a derivatisation step for detection of IBP, KPF and DCF. The advantage of the additional derivatisation step is the ability to produce two daughter ions for the determination of IBP whereas by LC-MS only precursor (parent) and one daughter ion for these compounds could be obtained [Vinci, et al., 2006] . This method involves the addition of acetonitrile to bovine milk followed by clean-up using Isolute TM C 18 solid phase extraction (SPE) cartridges and analysis by GC-MS/MS. To the best of our knowledge there are no 
Materials and Methods

Materials and reagents
Water, ethanol, ethyl acetate, methanol, acetonitrile, acetic acid, hydrochloric acid (37 %), n-hexane and iso-octane (HiPerSolv grade) were obtained from BDH (Merck, UK). Heptafluorobutyric Acid Anhydride was obtained from Pierce, (Pierce, USA). 
GC conditions
The GC system consisted of a Varian CP-3800 Gas Chromatograph coupled to a
Varian 1200 L Quadrupole MS and a Varian 8400 Autosampler (Varian, CA, USA).
The carrier gas was helium at flow of 1.5 mL min -1 . IBP, KPF, DCF and PBZ was 
MS/MS parameters
The analysis was performed using EI positive MS/MS with multiple reaction monitoring (MRM) mode. Two transitions per compound were used and the collision voltages were optimised as shown ( Table 2 
Milk samples
Milk obtained for use as negative controls was separated into 50 mL aliquots and stored at -20 °C. The milk was obtained from local supermarkets and was analysed in previous batches and milk found to contain no detectable residues of IBP, KPF, DCF and PBZ was used as negative controls.
Sample extraction and clean-up
Milk samples (5 ml) were aliquoted into 50 ml polypropylene tubes. The milk aliquots (5 mL) were fortified with internal standard at levels corresponding to 15 ng mL -1 by adding a 150 µL portion of a 500 ng mL -1 mix solution of d 3 -IBP, d 4 -DCF and d 10 -PBZ. Samples were fortified at levels corresponding to 5, 7.5 and 10 ng mL -1 by adding 50, 75 and 100 µL portions of a 500 ng mL -1 solution of IBP, KPF, DCF and PBZ. After fortification, samples were held for 15 min prior to extraction. Acetonitrile (5 mL) was added and the samples were vortexed (30 sec), centrifuged (3500 rpm, 10 o C) and the supernatant was transferred to a clean polypropylene tube. The sample pellet is re-extracted with 5 mL of acetonitrile and the supernatants are combined. 10 mM ascorbic acid (20 mL) and 1 M hydrochloric acid (0.2 mL) were added to the extracts and the pH of the samples were checked to ensure they were at pH 3 before proceeding to the solid phase extraction (SPE) stage. The sample extracts were purified by SPE using C 18 SPE cartridges. Sample extracts were loaded onto the cartridges (preconditioned with n-hexane:diethyl ether (50:50, v/v) (3 mL), methanol (3 mL) and water (5 mL). The samples were loaded onto cartridges under gravity. The cartridges were washed with 10 mM ascorbic acid (3 mL) and Samples are reconstituted in 50 µL of iso-octane. An aliquot (2 µL) is injected onto the GC column.
Matrix-Matched Calibration
Matrix matched calibration curves were prepared and used for quantification. Control milk previously tested and shown to contain no residues was prepared as above (2.4).
One control milk sample was used for each calibration standard level. Milk samples (5 ml) were aliquoted into 50 ml polypropylene tubes. Samples were fortified with internal standard at levels corresponding to 15 ng ml -1 by adding a 150 µL portion of a 500 ng mL -1 mix solution of d 3 -IBP, d 4 -DCF and d 10 -PBZ. Samples were fortified at levels corresponding to 0, 2, 5, 7.5, 10 and 20 ng ml -1 by adding 0, 20, 50, 75, 100 and 200 µL portions of a 500 ng mL -1 standard solution of IBP, KPF, DCF and PBZ. After fortification, samples were held for 15 min prior to the extraction procedure as described above (2.5). Calibration curves were prepared by plotting the response factor as a function of analyte concentration (0 to 20 ng ml -1 ) to quantify samples repeatability and within-laboratory reproducibility was calculated. The decision limit (CCα) of the method was calculated according to the calibration curve procedure using the intercept (value of the signal, y, where the concentration, x is equal to zero) and 2.33 times the standard error of the intercept for a set of data with 6 replicates at 3 levels. The detection capability (CCβ) was calculated by adding 1.64 times the standard error to the CCα.
Method validation
Results and Discussion
Preliminary experiments
The GC-MS/MS method was developed to provide confirmatory data for the analysis of bovine milk for IBP, KPF, DCF and PBZ. The MS/MS fragmentation conditions were investigated and collision energies were optimised. For a method to be deemed confirmatory four identification points are required. These identification points can be obtained by monitoring one precursor ion (parent mass) and two daughters (corresponding to strong and weak ion). 
Specificity
The technique of GC-MS/MS itself offers a high degree of selectivity and specificity.
To establish the selectivity/specificity of the method, a variety of milk samples were 
Linearity of the response
The linearity of the chromatographic response was tested with matrix matched curves using 6 calibration points in the concentration range of 0 to 20 ng mL -1 . The regression coefficients (r 2 ) for all the calibration curves used in this study were ≥ ≥ ≥ ≥ 0.99. Representative matrix matched calibration curves are shown ( Figure 6 ).
Accuracy
The accuracy of the method was determined using bovine milk samples fortified at 5.0, 7.5 and 10.0 ng ml −1 . Mean corrected recovery (n = 18) of the analyte, determined in three separate assays (Table 2) was between 104 and 112 % for IBP, KPF, DCF and PBZ.
Precision
The usefulness of suitable deuterated standards is demonstrated in the excellent repeatability and within-laboratory reproducibility obtained for IBP, DCF and PBZ (Table 2) . No deuterated analogue is available for KPF so poorer precision was obtained for this analyte. The precision of the method, expressed as RSD values for the within-lab reproducibility at the three levels of fortification (5, 7.5 and 10 ng ml -1 ), for IBP, DCF and PBZ was less than 8 %. The RSD values were less than 28 % for 
CCα and CCβ
The decision limit (CCα) is defined as the limit above which it can be concluded with an error probability of α, that a sample contains the analyte. In general, for non-MRL substances an α equal to 1 % is applied. The detection capability (CCβ) is the smallest content of the substance that may be detected, identified and quantified in a sample, with a statistical certainty of 1-β, were β = 5 %. CCα and CCβ were calculated using the intercept (value of the signal, y, were the concentration, x is equal to zero) and the standard error of the intercept for a set of data with 6 replicates at 3 levels (5.0, 7.5 and 10.0 ng ml -1 ). Blank milk was fortified at 1, 1.5 and 2 times the minimum required performance level of 5 ng ml -1 set for IBP, KPF, DCF and PBZ. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 Recently it was proposed by Community Reference Laboratories (CRLs) in Europe that laboratories should be capable of monitoring for KPF, DCF and PBZ in bovine milk at a level of 5 ng ml -1 and IBP at a level of 10 ng ml -1 in EU member states [SANCO, 2007] . This study shows that the required sensitivity was achieved for all compounds that easily meets the proposed levels. The method performs very well in terms of accuracy and within-laboratory reproducibility. For KPF improvements can be made if a suitable deuterated analogue becomes available.
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